The FDA granted marketing approval to Zydus Cadila for its Acyclovir for injection USP in 500 mg/vial and 1000 mg/vial strengths. The drug will be manufactured at the firm's facility in Ahmedabad, India.
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.